A Phase II, Open-Label, Multi-Dose Study of [89Zr]Zr-Df-IAB22M2C (CD8 cell PET tracer) PET/CT in Patients with Selected Advanced or Metastatic Solid Malignancies Scheduled to Receive Standard of Care Immunotherapy, as Single Agent or in Combination
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase II, Open-Label, Multi-Dose Study of [89Zr]Zr-Df-IAB22M2C (CD8 cell PET tracer) PET/CT in Patients with Selected Advanced or Metastatic Solid Malignancies Scheduled to Receive Standard of Care Immunotherapy, as Single Agent or in Combination ### Output: 